Establishment of subcutaneous transplantation platform for delivering induced pluripotent stem cell-derived insulin-producing cells.
Potential trend of regenerative treatment for type I diabetes has been introduced for more than a decade. However, the technologies regarding insulin-producing cell (IPC) production and transplantation are still being developed. Here, we propose the potential IPC production protocol employing mouse...
Saved in:
Main Authors: | Hong Thuan Tran, Watchareewan Rodprasert, Irma Padeta, Saranyou Oontawee, Steven Dwi Purbantoro, Anatcha Thongsit, Parkpoom Siriarchavatana, Sayamon Srisuwatanasagul, Hiroshi Egusa, Thanaphum Osathanon, Chenphop Sawangmake |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2025-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0318204 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Small extracellular vesicles derived from sequential stimulation of canine adipose-derived mesenchymal stem cells enhance anti-inflammatory activity
by: Saranyou Oontawee, et al.
Published: (2025-01-01) -
Effect of Mechanical Force Stress on the Inflammatory Response in Human Periodontal Ligament Cells
by: Thira Rojasawasthien, et al.
Published: (2025-02-01) -
Multipotent to Pluripotent Properties of Adult Stem Cells
by: Deepa Bhartiya, et al.
Published: (2013-01-01) -
Advances in Induced Pluripotent Stem Cell Technologies
by: Rajarshi Pal, et al.
Published: (2012-01-01) -
Induced Pluripotent Stem Cells in Cardiovascular Medicine
by: Toru Egashira, et al.
Published: (2011-01-01)